Pfizer’s manufacturing arm at risk from Trump tariffs in Europe, Bourla saysnews2025-02-19T11:21:20+00:00February 19th, 2025|Endpoints News|
Former FDA chief calls job cuts ‘haphazard, poorly thought-out’news2025-02-18T21:10:54+00:00February 18th, 2025|Endpoints News|
NIH payment cuts are ‘reasoned and rational,’ government saysnews2025-02-18T20:33:45+00:00February 18th, 2025|Endpoints News|
Novo looks to recoup $830M from hypertension drug partnernews2025-02-18T19:44:49+00:00February 18th, 2025|Endpoints News|
Siegfried’s stock slips over dampened sales outlook for 2025 news2025-02-18T17:50:39+00:00February 18th, 2025|Endpoints News|
Hikma takes Amarin’s ‘skinny label’ fight to the Supreme Courtnews2025-02-18T14:10:51+00:00February 18th, 2025|Endpoints News|
Bavarian Nordic wins FDA OK for chikungunya vaccine in challenge to Valneva news2025-02-18T13:31:58+00:00February 18th, 2025|Endpoints News|
FDA approves Ono’s rare joint tumor drug, setting up battle with Daiichinews2025-02-18T11:51:28+00:00February 18th, 2025|Endpoints News|
GSK follows Pfizer in meningococcal vaccine race with new FDA nodnews2025-02-15T03:26:57+00:00February 15th, 2025|Endpoints News|
J&J to face pivotal hearing over its $8B talc settlement plannews2025-02-14T20:05:10+00:00February 14th, 2025|Endpoints News|
